Nutritional iron deprivation attenuates kainate-induced neurotoxicity in rats: Implications for involvement of iron in neurodegeneration

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 94-114

  Shoham, S ^a   Youdim, M B H ^b  

^a HERZOG HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Epilepsy; Hippocampus; Iron; Kainate; Microglia; Neurodegeneration; Oxidative stress; Piriform cortex; Thalamus; Zinc

Indexed keywords

IRON; KAINIC ACID; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTORHINAL CORTEX; EPILEPSY; GLIOSIS; HIPPOCAMPUS; IRON RESTRICTION; MALE; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PYRIFORM CORTEX; RAT; SILVER IMPREGNATION; THALAMUS;

ANIMALIA; RODENTIA;

EID: 1842504330     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.008     Document Type: Article

References (80)

1. COLOER, B.W. et al. 1996. Neuronal synchrony in relation to burst discharge in epileptic human temporal lobes. J. Neurophysiol. 75: 2496-2508.
2. BEN-ARI, Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
3. LOTHMAN, E.W. & R.C. COLLINS. 1981. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic, and neuropathological correlates. Brain Res. 218: 299-318.
4. CHESLER, M. & K. KAILA. 1992. Modulation of pH by neuronal activity. TINS 15: 396-402.
5. LASSMAN, H. et al. 1984. The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neuroscience 13: 691-704.
6. CHARRIAUT-MARLANGUE, D., A. AGOUN-ZOUAOUI, Y. REPRESA & Y. BEN-ARI. 1996. Apoptotic features of selective neuronal death in ischemia, epilepsy, and gp120 toxicity. TINS 19: 109-114.
7. COYLE, J.T. & P. PUTTFARCKEN. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
8. HIRATA, H. & J.L. CADET. 1997. Kainate-induced hippocampal DNA damage is attenuated in superoxide dismutase transgenic mice. Mol. Brain Res. 48: 145-148.
9. KONDO, T. et al. 1997. DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J. Cereb. Blood Flow Metab. 17: 241-256.
10. CHEN, S.T. & J.I. CHUANG. 1999. The antioxidant melatonin reduces cortical neuronal death after intrastriatal injection of kainate in the rat. Exp. Brain Res. 124: 241-247.
11. LOCKHART, B. et al. 2001. Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration. Eur. J. Pharmacol. 416: 59-68.
12. KIM, H.C. et al. 2000. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874: 15-23.
13. CECCON, M. et al. 2000. Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid. Brain Res. 862: 83-89.
14. SKAPER, S.D. et al. 1999. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann. N.Y. Acad. Sci. 890: 107-118.
15. HALLIWELL, B.J. & J.M.C. GUTTERIDGE. 1984. Oxygen toxicity, oxygen radicals, transition metals, and disease. Biochem. J. 219: 1-14.
16. BEARD, J.L., J.R. CONNOR & B.C. JONES. 1993. Brain iron: location and function. Prog. Food Nutr. Sci. 17: 183-221.
17. SHOHAM, S. & M.B.H. YOUDIM. 2000. Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. Cell. Mol. Biol. (Noisy-Le-Grand) 46: 743-760.
18. YOUDIM, M.B.H., D. BEN-SHACHAR & P. RIEOERER. 1990. The role of monoamine oxidase, iron-melatonin interaction, and intracellular calcium in Parkinson's disease. J. Neural Transm. Suppl. 32: 239-248.
19. YOUDIM, M.B.H. & P. RIEDERER. 1993. The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. Neural Transm. Suppl. 40: 57-67.
20. YOUDIM, M.B.H. & P. RIEDERER. 2003. Iron in normal and pathological brain. In Encyclopedia of Neuroscience. Elsevier. Amsterdam. In press.
21. BEN-SHACHAR, D., G. ESHEL, J.P.M. FINBERG & M.B.H. YOUDIM. 1991. The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal neurons. J. Neurochem. 56: 1441-1444.
22. KAUR, D. et al. 2003. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899-909.
23. BEN-SHACHAR, D. et al. 2003. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats. Neuropharmacology. In press.
24. LAN, J. & D.H. JIANG. 1997. Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease. J. Neural Transm. 104: 649-660.
25. LEVENSON, C.W. et al. 2003. Effect of dietary iron on motor behaviour and neuronal death in an experimental model of parkinsonism. J. Am. Aging Assoc. In press.
26. HILL, J.M. & C. SWITZER III. 1984. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11: 596-603.
27. WANG, X.S., W.Y. ONG & J.R. CONNOR. 2002. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp. Brain Res. 143: 137-148.
28. WANG, X.S., W.Y. ONG & J.R. CONNOR. 2002. A light and electron microscopic study of divalent metal transporter-1 distribution in the rat hippocampus, after kainate-induced neuronal injury. Exp. Neurol. 177: 193-201.
29. WANG, X.S., W.Y. ONG & J.R. CONNOR. 2003. Quinacrine attenuates increases in divalent metal transporter-1 and iron levels in the rat hippocampus, after kainate-induced neuronal injury. Neuroscience 120: 21-29.
30. SHOHAM, S., E. WERTMAN & P. EBSTEIN. 1992. Iron accumulation in the rat basal ganglia after excitatory amino acid injections - dissociation from neuronal loss. Exp. Neurol. 118: 227-241.
31. ONG, W.Y. et al. 1999. A nuclear microscopic study of elemental changes in the rat hippocampus after kainite-induced neuronal injury. J. Neurochem. 72: 1574-1579.
32. MATSUOKA, Y. et al. 1998. Kainic acid induction of heme oxygenase in vivo and in vitro. Neuroscience 85: 1223-1233.
33. DALLMAN, P.R., M.N. SIIMES & E.C. MANIES. 1975. Brain iron: persistent deficiency following short term iron deprivation in the young rat. Br. J. Haematol. 31: 209-215.
34. YOUDIM, M.B. & A.R. GREEN. 1978. Iron deficiency and neurotransmitter synthesis and function. Proc. Nutr. Soc. 37: 173-179.
35. YOUDIM, M.B.H., D. BEN-SHACHAR & S. YEHUDA. 1989. Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am. J. Clin. Nutr. 50: 607-617.
36. YOUDIM, M.B. et al. 1980. The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats. Neuropharmacology 19: 259-267.
37. SHOHAM, S., Y. GLINKA, Z. TANNE & M.B.H. YOUDIM. 1996. Brain iron: function and dysfunction in relation to cognitive processes. In Iron Nutrition in Health and Disease, pp. 205-218. Libbey. London.
38. TERADA, L.S., I.R. WILLINGHAM & J.E. REPINE. 1992. Iron and stroke. In Iron and Human Disease, pp. 313-327. CRC Press. Boca Raton, FL.
39. CHOI, D.W., M. YOKOYAMA & J. KOH. 1988. Zinc neurotoxicity in cortical cell culture. Neuroscience 24: 67-79.
40. FREDERICKSON, C.J., M.D. HERNANDEZ & J.F. MCGINTY. 1989. Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res. 480: 317-321.
41. KIM, E.Y. et al. 1999. Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur. J. Neurosci. 11: 327-334.
42. MCCALL, M.G. et al. 1960. Studies in iron metabolism. 1. The experimental production of iron deficiency in the growing rat. Br. J. Nutr. 16: 297-304.
43. TANNE, Z. et al. 1994. Ultrastructural and cytochemical changes in the heart of iron-deficient rats. Biochem. Pharmacol. 47: 1759-1766.
44. BEN-SHACHAR, D., R. ASHKENAZI & M.B. YOUDIM. 1986. Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats. Int. J. Dev. Neurosci. 4: 81-88.
45. SPERK, G. et al. 1985. Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical, and histopathological changes. Brain Res. 338: 289-295.
46. GALLYAS, F., F.H. GULDNER, G. ZOLTAGY & R. WOLFF. 1990. Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology. Acta Neuropathol. 79: 620-628.
47. SHOHAM, S. & R.P. EBSTEIN. 1997. The distribution of beta amyloid precursor protein in rat cortex after kainate-induced seizures. Exp. Neurol. 147: 361-376.
48. PAXINOS, G. & C. WATSON. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press. San Diego.
49. REGAN, R.F. & S.S. PANTER. 1996. Hemoglobin potentiates excitotoxic injury in cortical cell culture. Neurotrauma 13: 223-231.
50. BRUCE, A.J. & M. BAUDRY. 1995. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radical Biol. Med. 18: 993-1002.
51. CANDELARIO-JALIL, E. et al. 2001. Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J. Appl. Toxicol. 21: 403-407.
52. LAYTON, M.E. & T.L. PAZDERNIK. 1999. Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats. J. Mol. Neurosci. 13: 63-68.
53. TAKEDA, A., M. OHNUMA, J. SAWASHITA & S. OKADA. 1997. Zinc transport in the rat olfactory system. Neurosci. Lett. 225: 69-71.
54. MENGUAL, E., C. CASANOVAS-AGUILAR, J. PEREZ-CLAUSELL & J.M. GIMENEZ-AMAYA. 2001. Thalamic distribution of zinc-rich terminal fields and neurons of origin in the rat. Neuroscience 102: 863-884.
55. 45Ca uptake and acute toxicity mediated by the N-methyl-D-aspartate receptor: the effect of metal binding agents and transition metal ions. J. Neurochem. 61: 518-525.
56. MATSUSHITA, K. et al. 1996. Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Res. 743: 362-365.
57. OKAZAKI, M.M. & J. V. NADLER. 1988. Protective effects of mossy fiber lesions against kainic acid-induced seizures and neuronal degeneration. Neuroscience 26: 763-781.
58. SHOHAM, S. & M.B.H. YOUDIM. 2002. The effects of iron deficiency and iron and zinc supplementation on rat hippocampus ferritin. J. Neural Transm. 109: 1241-1256.
59. STAFSTROM, C.E., J.L. THOMPSON & G.L. HOLMES. 1992. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Dev. Brain Res. 65: 227-236.
60. MATTSON, M.P. 2000. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res. 886: 47-53.
61. COOK, C.I. & B.P. YU. 1998. Iron accumulation in aging: modulation by dietary restriction. Mech. Ageing Dev. 102: 1-13.
62. SOHAL, R.S. & R. WEINDRUCH. 1996. Oxidative stress, caloric restriction, and aging. Science 273: 59-63.
63. BOJE, K.M. & P.K. ARORA. 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587: 250-256.
64. EYUPOGLU, I.Y., I. BECHMANN & R. NITSCH. 2003. Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J. 17: 1110-1111.
65. LIN, M. et al. 1997. Role of iron in NF-kB activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272: G1355-G1364.
66. YOUDIM, M.B., E. GRUNBLATT & S. MANDEL. 1999. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration: prospects for neuroprotection in Parkinson's disease with iron chelators. Ann. N.Y. Acad. Sci. 890: 7-25.
67. O'NEILL, L.A.J. & C. KALTSCMIDT. 1997. NF-kB: a crucial transcription factor for glial and neuronal cell function. TINS 20: 252-258.
68. MILLER, W.J., D.G. MACGREGOR & T.W. STONE. 1994. Time course of purine protection against kainate-induced increase in hippocampal [3H]-PK11195 binding. Brain Res. Bull. 34: 133-136.
69. TIKKA, T.M. & J.E. KOISTINAHO. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166: 7527-7533.
70. XIE, X., R.C. HIDER & T.G. SMART. 1994. Modulation of GABA-mediated synaptic transmission by endogenous zinc in the immature rat hippocampus in vitro. J. Physiol. 478(pt. 1): 75-86.
71. HEGG, C.C. & S.A. THAYER. 1999. Monocytic cells secrete factors that evoke excitatory synaptic activity in rat hippocampal cultures. Eur. J. Pharmacol. 385: 231-237.
72. PATT, A. et al. 1988. Xanthine oxidase-derived hydrogen peroxide and iron contribute to ischemia-reperfusion-induced edema in gerbil brain. J. Clin. Invest. 81: 1556-1564.
73. PATT, A. et al. 1990. Iron depletion or chelation reduces ischemia-reperfusion-induced edema in gerbil brains. J. Pediatr. Surg. 25: 224-236.
74. CONNOR, J.R. 1992. Proteins of iron regulation in the brain in Alzheimer's disease. In Iron and Human Disease, pp. 366-395. CRC Press. Boca Raton, FL.
75. JELLINGER, K. et al. 1990. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. Parkinson's Dis. Dementia Sect. 2: 327-340.
76. THOMPSON, K.J., S. SHOHAM & J.R. CONNOR. 2001. Iron and neurodegenerative disorders. Brain Res. Bull. 55: 155-164.
77. CRONIN, J., A. OBENHAUS, C.R. HOUSER & F.E. DUDEK. 1992. Electrophysiology of dentate granule cells after kainate-induced synaptic reorganization of the mossy fibres. Brain Res. 573: 305-310.
78. SLOVITER, R.S. 1992. Possible functional consequences of synaptic reorganization in the dentate gyms of kainate-treated rats. Neurosci. Lett. 137: 91-96.
79. BABB, T.L. et al. 1991. Synaptic reorganization by mossy fibres in human epileptic fascia dentata. Neuroscience 42: 351-363.
80. OJEMANN, G.A. 1997. Treatment of temporal lobe epilepsy. Annu. Rev. Med. 48: 317-328.